The adverse effects of antiepileptic drugs in children

Sanjeev V Kothare1, Joseph Kaleyias

  • 1St Christopher's Hospital for Children, Section of Neurology, Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA 19134, USA. skothare@drexelmed.edu

Insights

Antiepileptic drugs (AEDs) have similar efficacy, making adverse effects (AEs) crucial for selection. This review details neurocognitive, developmental, and other AEs, emphasizing pediatric and pregnancy risks.

Area of Science:

  • Pharmacology
  • Neurology
  • Teratology

Background:

  • Antiepileptic drugs (AEDs) exhibit comparable efficacy, necessitating adverse effect (AE) evaluation for treatment selection.
  • Neurocognitive AEs are common with AED use, particularly in high-risk populations.
  • Concerns extend beyond first-trimester teratogenesis to potential neurocognitive developmental delays in later pregnancy.

Purpose of the Study:

  • To review and classify adverse effects of antiepileptic drugs (AEDs).
  • To highlight age-specific AEs, with a focus on pediatric populations.
  • To discuss the impact of AEDs on various physiological functions.

Main Methods:

  • Literature review of antiepileptic drug adverse effects.
  • Analysis of neurocognitive, teratogenic, and other physiological impacts.
  • Classification of adverse effects based on various parameters.

Main Results:

  • Neurocognitive adverse effects are nearly inevitable with AED use.
  • Potential for neurocognitive developmental delay exists with AED use throughout pregnancy.
  • AEDs are associated with decreased bone mineral density, altered lipid profiles, weight changes, and endocrine/reproductive dysfunction.
  • Age-specific AEs, particularly in pediatric populations, are influenced by pharmacokinetic differences.

Conclusions:

  • Adverse effects, including neurocognitive and developmental issues, are critical considerations in AED selection.
  • Comprehensive understanding of AED AEs is vital for all patient populations, especially pregnant women and children.
  • A structured classification of AED AEs aids in clinical management and research.

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...